Sign in
Early Switch to the Dexamethasone Implant After Sub-Optimal Response to Anti-VEGF Therapy for Diabetic Macular Edema
Shawn Kavoussi, MD
Annual Meeting Talks
2021
Fluctuations in Central Subfield Thickness Associated With Worse Visual Outcomes in Patients With Diabetic Macular Edema in Clinical Trial Setting
Matthew Starr, MD
Updates from the Field
Efficacy, Durability, and Safety of Faricimab in DME: 2-Year Results From the Phase 3 YOSEMITE and RHINE Trials
Jennifer I. Lim, MD, FARVO, FASRS
2022
Category: Diabetic Retinopathy